|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Combo: DNA & protein vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2011-03-10|
|Study Made Public:||2012-02-14|
Evaluate the potential use of SIV Env in generating neutralizing antibodies against HIV-1
CAVD 333 is an immunogenicity study evaluating the potential use of SIV Env in generating neutralizing antibodies against HIV-1.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.